Mifepristone’s safety in medication abortions has been well established over more than two decades, but legal wrangling leaves the future of the drug hanging in the balance.
Academic rigour, journalistic flair
Articles on Misoprostol
Displaying all articles
The Supreme Court’s ruling on mifepristone keeps the drug accessible for now, but its future is still in limbo.
The increase in abortion restrictions may also lead to a decline in access to emergency contraceptives.
If the ruling to reverse the use of mifepristone stands, it will not only severely restrict abortion access for women throughout the US – it will have far-reaching effects on health care.
A rash of pending lawsuits raises questions about the FDA’s approval of mifepristone two decades ago, whether the drug can be legally mailed and the constitutional right to interstate commerce.
The FDA’s allowance for pharmacies to dispense mifepristone will broaden access to the two-pill mifepristone-misoprostol regimen of medication abortion, which is 95% to 98% effective.
The fall of Roe v. Wade will result in more people deciding to privately end a pregnancy, a new study finds. But how often people will turn to safe versus unsafe options remains to be seen.
Abortion pills are available online, and many of them are safe. But not all sites have been properly vetted for legitimacy.
Top contributors
-
Associate Professor of Family Medicine, School of Medicine, University of Washington
-
Associate Professor of Legal Studies and Political Science, UMass Amherst
-
Associate Professor of Obstetrics, Gynecology and Gynecologic Surgery, University of California, San Francisco
-
Professor of Law, University of Virginia
-
Professor of law, George Washington University
-
Associate Professor of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco
-
Service Assistant Professor in Family Medicine, West Virginia University
